KCM
ABBV icon

KRS Capital Management’s AbbVie ABBV Stock Holding History

KRS Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
8,572
+219
+3% +$47.1K 1% 18
2026
Q1 		$1.82M Buy
8,353
+3
+0% +$665 1.11% 14
2025
Q4 		$1.91M Buy
8,350
+3
+0% +$683 1.1% 17
2025
Q3 		$1.93M Sell
8,347
-26
-0.3% -$5.29K 1.17% 15
2025
Q2 		$1.55M Buy
8,373
+40
+0.5% +$7.43K 1.04% 19
2025
Q1 		$1.75M Sell
8,333
-26
-0.3% -$5.05K 1.39% 11
2024
Q4 		$1.49M Buy
8,359
+31
+0.4% +$5.7K 1.05% 19
2024
Q3 		$1.64M Sell
8,328
-453
-5% -$84.5K 1.2% 14
2024
Q2 		$1.51M Sell
8,781
-223
-2% -$36.9K 1.13% 16
2024
Q1 		$1.64M Sell
9,004
-690
-7% -$119K 1.32% 13
2023
Q4 		$1.5M Sell
9,694
-260
-3% -$37.9K 1.4% 13
2023
Q3 		$1.48M Buy
9,954
+284
+3% +$41.7K 1.58% 11
2023
Q2 		$1.3M Buy
9,670
+25
+0.3% +$3.67K 1.3% 13
2023
Q1 		$1.54M Buy
9,645
+74
+0.8% +$11.3K 1.73% 8
2022
Q4 		$1.55M Buy
9,571
+24
+0.3% +$3.68K 2.11% 6
2022
Q3 		$1.28M Buy
9,547
+47
+0.5% +$6.74K 1.77% 8
2022
Q2 		$1.46M Sell
9,500
-26
-0.3% -$3.97K 2.07% 5
2022
Q1 		$1.54M Buy
9,526
+22
+0.2% +$3.2K 1.67% 9
2021
Q4 		$1.29M Buy
+9,504
New +$1.12M 1.1% 17

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

KRS Capital Management's ABBV Position: Q2 2026 in Review

KRS Capital Management increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $47.1K and bringing the position to 8,572 shares worth $2.16M. The position accounts for 1% of the portfolio, ranked #18.

KRS Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KRS Capital Management held 8,572 shares of AbbVie worth $2.16M as of Q2 2026.
  • KRS Capital Management bought 219 AbbVie shares in Q2 2026, an estimated $47.1K.
  • AbbVie made up 1% of KRS Capital Management's portfolio in Q2 2026, its #18 holding.
  • KRS Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.